Jul 22, 2021 7:15am EDT ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference
Jun 08, 2021 7:30am EDT ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease
May 27, 2021 7:30am EDT ProMIS Neurosciences appoints renowned scientist, Dr. David Wishart as Chief Physics Officer
May 21, 2021 8:30am EDT ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development
May 19, 2021 6:30am EDT ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors